Kantum Research Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Kantum Research General Information

Description

Developer of a market research platform designed to provide strategic insight and development upon research theory. The company's platform offers initial inquiries, appropriate data collection avenues, analysis processes, and research support across a range of both qualitative and quantitative methodologies, enabling companies to ensure projects are completed on time and as per specifications.

Contact Information

Formerly Known As
Kantum Diagnostics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 75 South Main Street
  • Suite 7-160
  • Concord, NH 03301
  • United States
Primary Industry
Business/Productivity Software
Other Industries
Enterprise Systems (Healthcare)
Media and Information Services (B2B)
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 75 South Main Street
  • Suite 7-160
  • Concord, NH 03301
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kantum Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 16-Sep-2025 Completed Out of Business
3. Secondary Transaction - Private Completed Generating Revenue
2. Seed Round 12-Jul-2021 $5.52M $5.52M Completed Generating Revenue
1. Grant 15-Nov-2017 $200K Completed Startup
To view Kantum Research’s complete valuation and funding history, request access »

Kantum Research Patents

Kantum Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3955907-A1 Pharmaceutical formulations containing p2y14 antagonists Inactive 16-Apr-2019
EP-3955907-A4 Pharmaceutical formulations containing p2y14 antagonists Inactive 16-Apr-2019
US-20220202799-A1 Pharmaceutical formulations containing p2y14 antagonists Inactive 16-Apr-2019
WO-2020214510-A1 Pharmaceutical formulations containing p2y14 antagonists Inactive 16-Apr-2019
US-20210123923-A1 Methods of monitoring, treating, and preventing renal inflammation associated with nephrotoxicity Inactive 08-Jun-2018 A61K31/451
To view Kantum Research’s complete patent history, request access »

Kantum Research FAQs

  • When was Kantum Research founded?

    Kantum Research was founded in 2016.

  • Where is Kantum Research headquartered?

    Kantum Research is headquartered in Concord, NH.

  • What industry is Kantum Research in?

    Kantum Research’s primary industry is Business/Productivity Software.

  • Is Kantum Research a private or public company?

    Kantum Research is a Private company.

  • What is Kantum Research’s current revenue?

    The current revenue for Kantum Research is .

  • How much funding has Kantum Research raised over time?

    Kantum Research has raised $5.52M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process